학술논문
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.
Document Type
research
Author
Source
Journal of the American Academy of Dermatology; Dec2019, Vol. 81 Issue 6, p1405-1409, 5p
Subject
Language
ISSN
01909622